In total, 517 consecutively diagnosed patients with primary IDH-wildtype glioblastoma or Grade 4 IDH-mutant astrocytoma were identified; 27 patients who were not UK residents were excluded from all of the analyses, leaving a total of 490 patients. This evidence concerns the gene IDH1 and glioblastoma.